Erbisol - immunomodulatory  Packing Erbisol

Pharmacological properties

According to the instructions Erbisol contains bioactive peptides with low molecular weight. They are able to activate the inherent nature of the body's control systems responsible for the elimination of pathological changes occur.

Erbisol affects the immune system, activating its immunomodulatory effect. Immunomodulatory effect is realized through the macrophages, which are responsible for the regeneration of damaged cells and the destruction of those that can not be reversed. Macrophages different species restore the balance between cellular and humoral immunity in cancer, autoimmune and allergic processes. Studies have shown a decrease in the frequency of required courses of chemotherapy and radio-wave using Erbisol in cancer patients.

Additional effects include increased use Erbisol action of antibiotics, interferons, introduced into the body, while the drug reduces their side effects.

The drug accelerates the healing of ulcers and erosions of the mucous membranes in the digestive tract increases the regenerative capacity of tissues, which also promotes the healing of wounds, injuries, fractures. Positive reviews Erbisol received from dentists who use it in the treatment of periodontitis and paradontosis.

This tool activates the regenerative processes in the liver when it is viral, toxic, or drug-induced. As a result of his use of dead liver cells are replaced by new ones. Antioxidant and membrane-stabilizing effects Erbisol normalize the hepatocytes, which manifests itself at the level of the body disappearance of pain, dyspeptic symptoms and asthenovegetative.

When using Erbisol in treatment of diabetes, it reduces the autoimmune aggression, and activating macrophages, stimulates regeneration of damaged beta cells of the pancreas. It is also a positive effect on drug formed complications of diabetes as neuropathy, angiopathy, trophic disorders. Its use often leads to a decrease in the required dose of insulin and a prolonged remission. The positive effect on the metabolism and improve cardiac contractility improve the quality of life of patients with diabetes mellitus.

As an adaptogen drug is able to enhance the protective properties of the body. It is included in regimens effects of environmental pollution and radiation injuries. Immunomodulatory effects Erbisol Review begins to appear 5-7 days, reaching a maximum at 21 hours, and holding at the same level prior to 10 days. Hepatoprotective effect is manifested after 2-3 injections.

Product form

Erbisol released into solution in ampoules of 1 and 2 ml.

Indications Erbisol

In gastroenterology drug used to treat hepatitis and various non-inflammatory lesions of the liver - steatosis, hepatopathy, cirrhosis, stomach ulcers and 12 duodenal ulcer, ulcerative colitis.

According to the instructions  Capsules Erbisol
 Erbisol also shows the radioactive defeat and Ecopathology.

The drug used in diabetes, non-specific lesions of the lung, autoimmune thyroiditis, angiopathy, in allergic and autoimmune lesions, periodontitis, parodontosis. Positive reviews Erbisol obtained from experts in the field of gerontology. In surgery and traumatology drug used to treat injuries, fractures, wounds, trophic ulcers, bedsores.

In oncology practice Erbisol as a drug used in chemotherapy support, radiotherapy for the prevention of metastases surgical interventions, as a stimulant of antitumor protection.


Erbisol not used in the individual and his intolerance in children.

Instructions for use Erbisol

The drug is administered following parenteral routes - intravenous, intra-arterial, or intramuscular injection. For adults, the dosage is from 2 to 4 ml of the drug each day course lasts 20 days. When the drug is administered 1 time a day, preferably before going to bed to do it, in 3 hours after a meal. In the case of administration it requires two, one of them will do optimally 6-8 am, for 1-1 and 5 hours before mealtime.

Allergic and autoimmune processes gepatopatiitrebuyut Erbisol administration of 2 ml per day. In the case of periodontitis and paradontosis first 10 days make 4 ml, and the remaining 10 days - 2 ml.

In drug treatment, diabetes, autoimmune thyroiditis, peptic ulcer, ulcerative colitis, injuries, fractures, liver cirrhosis, asthenia daily dose of 4 ml of 20 consecutive days.

When cancer pathology to accompany radiowave therapy instructions Erbisol appoint 2 ml in the morning and in the evening of 20 consecutive days. During chemotherapy, the dose is 2 ml for a night at 12-25 days.

Side effects Erbisol

Review Erbisol well tolerated. Sometimes, in the early days of receiving it can cause exacerbation of chronic inflammation, which is treated as part of the treatment process. We can not exclude the risk of allergic reactions.